Pacific Bio (PACB) Q3 Revenue Misses Estimates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Pacific Bio (PACB) Q3 Revenue Misses Estimates

Piper Jaffray Upgrades Pacific Biosciences of California (PACB) to Overweight

October 23, 2015 7:09 AM EDT

Piper Jaffray upgraded Pacific Biosciences of California (NASDAQ: PACB) from Neutral to Overweight with a price target of $9.00 (from $7.00).

Analyst William R. Quirk commented, "Pacific Biosciences reported 3Q15 revenue of $13.9M, below our $16.4M estimate and the Street's $15.8M expectations. Ongoing... More